RESUMEN
BACKGROUND: The Unified Protocol for Emotional Disorders (UP) for emotional regulation manifests effective results in a broad range of mental disorders. The UP efficacy was tested in several countries, but it has not been tested within Mexican population. It is crucial to do more research and implement effective protocols to intervene Mexican population with Anxiety Disorders (AD). OBJECTIVE: This study aims to examine and describe the research procedures and treatment interventions of the UP in a Randomized Controlled Trial (RCT), to approach and treat AD in patients in 2 Mexican borderland cities, by applying the UP and an Electroencephalogram (EGG) neuro screening. METHODS: The enrolled patients will be randomized in a two-arm control trial with repeated measures, comprising between 18 and 60 years, that were diagnosed with an AD, and low scored in depression symptoms and suicidal ideation. The study will comprise of two conditions: an intervention group clinical trial with the UP or a waiting list control. The primary outcome measures will be applied on AD quantitative self-reports and a gamma activity by EGG before and after the intervention and in follow-ups of 3 and 6 months. The participants in the waiting list group, will receive the treatment after the trial first group completes the treatment. CONCLUSIONS: Processes and outcomes of this project, will provide evidence in order to apply the UP in a broader population with AD and other mental disorders also covered by this protocol, such as depression and borderline personality disorder in a broader Mexican population, a country that suffers with a major health issue with an increasing rate of mental disorders and scarce psychological and health coverage.
RESUMEN
This article deals with current concepts about severe hypertension. This is defined by recorded values of more than 20 mmHg above the 97th percentile for weight and height. Exceptionally it is asymptomatic, abut most of the time presents with signs of hypertensive encephalopathy and/or hypertensive cardiopathy, cardiac failure and/or acute pulmonary edema. The most frequent causes in the Hospital Infantil de México Federico Gómez were: diffuse acute glomerulonephritis, segmental renal hypoplasia, renovascular hypertension and end-stage renal disease. First of all, on admission in the emergency room, the hypertensive child must be treated with rapid-acting drugs such as calcium channel blockers, sodium nitroprusside or diazoxide. Secondly, quick laboratory examinations as urinalysis, serum electrolytes and BUN must be performed to elaborate a presumptive diagnosis, in order to choice a therapy upon the pathophysiology. According to this thought, furosemide administration is mandatory in acute glomerulonephritis and could be supported by nifedipine. In renal hypoplasia and in renovascular hypertension the use of convertase enzyme inhibitors is indicated in the first place and may be supported by propranolol and/or diuretics. Finally, in hypertension due to end-stage renal disease, peritoneal dialysis with hypertonic solutions or ultrafiltration in chronic hemodialysis program are usually needed.